Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95,178 | -74,163 | -65,715 | -29,336 | -16,517 |
| Depreciation Amortization | 350 | 319 | 221 | 143 | 87 |
| Accounts receivable | 373 | -308 | 1,915 | -2,889 | 140 |
| Other Working Capital | 16,381 | -227 | 8,064 | -1,104 | 2,148 |
| Other Operating Activity | 4,680 | 5,715 | 2,338 | 5,816 | 1,644 |
| Operating Cash Flow | $-73,394 | $-68,664 | $-53,177 | $-27,370 | $-12,498 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -26,013 | -39,000 | -17,000 | -23,000 | -28,000 |
| PPE Investments | -1,018 | -557 | -1,485 | -424 | -500 |
| Purchase Of Investment | -18,951 | -38,652 | -22,839 | -31,700 | -72,518 |
| Sale Of Investment | 87,851 | 66,454 | 79,079 | 40,106 | 22,502 |
| Investing Cash Flow | $41,869 | $-11,755 | $37,755 | $-15,018 | $-78,516 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 33,903 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -476 | N/A |
| Common Stock Issued | 14,079 | 92,374 | 161 | 55,539 | 66,831 |
| Other Financing Activity | -32 | 0 | -21 | -32 | -30 |
| Financing Cash Flow | $47,950 | $92,374 | $140 | $55,031 | $66,801 |
| Exchange Rate Effect | 41 | -43 | 48 | 2 | N/A |
| Beginning Cash Position | 28,118 | 16,206 | 31,440 | 18,795 | 43,008 |
| End Cash Position | 44,584 | 28,118 | 16,206 | 31,440 | 18,795 |
| Net Cash Flow | $16,466 | $11,912 | $-15,234 | $12,645 | $-24,213 |
| Free Cash Flow | |||||
| Operating Cash Flow | -73,394 | -68,664 | -53,177 | -27,370 | -12,498 |
| Capital Expenditure | -1,058 | -567 | -1,518 | -424 | -500 |
| Free Cash Flow | -74,452 | -69,231 | -54,695 | -27,794 | -12,998 |